Provided by Tiger Fintech (Singapore) Pte. Ltd.

Gain Therapeutics, Inc.

1.44
-0.0200-1.37%
Post-market: 1.440.00000.00%16:05 EDT
Volume:246.31K
Turnover:356.82K
Market Cap:49.78M
PE:-1.76
High:1.52
Open:1.46
Low:1.41
Close:1.46
Loading ...

Gain Therapeutics to Present at BTIG Annual Virtual Biotechnology Conference

GlobeNewswire
·
24 Jul

Gain Therapeutics Announces $7 Million Public Offering

TIPRANKS
·
17 Jul

Gain Therapeutics Inc. Files Prospectus for Proposed Public Offering to Advance Neurodegenerative Disease Treatment

Reuters
·
17 Jul

BUZZ-U.S. STOCKS ON THE MOVE-Commvault Systems, Rockwell Automation, Tesla

Reuters
·
17 Jul

Gain Therapeutics Announces Pricing of $7.0 Million Public Offering

GlobeNewswire
·
16 Jul

BUZZ-Gain Therapeutics falls on equity offering plans

Reuters
·
16 Jul

Gain Therapeutics announces common stock, warrants offering

TIPRANKS
·
16 Jul

Gain Therapeutics Inc. Announces Proposed Public Offering of Common Stock and Warrants to Advance Neurodegenerative Disease Research

Reuters
·
16 Jul

Analysts Offer Insights on Healthcare Companies: RxSight (RXST), Gain Therapeutics (GANX) and Edwards Lifesciences (EW)

TIPRANKS
·
09 Jul

Gain Therapeutics Price Target Maintained With a $8.00/Share by HC Wainwright & Co.

Dow Jones
·
03 Jul

Promising Developments and Strategic Advancements Propel Gain Therapeutics to ‘Buy’ Rating

TIPRANKS
·
03 Jul

Scotiabank Sticks to Its Buy Rating for Gain Therapeutics (GANX)

TIPRANKS
·
02 Jul

Gain Therapeutics Inc. Achieves Target Enrollment in Phase 1b Clinical Trial for GT-02287 in Parkinson’s Disease; Biomarker Results Expected Sooner Than Planned

Reuters
·
01 Jul

H.C. Wainwright Keeps Their Buy Rating on Gain Therapeutics (GANX)

TIPRANKS
·
01 Jul

Gain Therapeutics Inc. Held Annual Stockholder Meeting

Reuters
·
25 Jun

Gain Therapeutics Inc. to Present at H.C. Wainwright Neuro Perspectives Hybrid Conference and BIO 2025

Reuters
·
10 Jun

Gain Therapeutics Inc. Announces Oral Presentation at GBA1 Meeting 2025 in Montreal

Reuters
·
29 May

Gain Therapeutics Files $100 Million Mixed Shelf

MT Newswires Live
·
29 May

Gain Therapeutics files $100M mixed securities shelf

TIPRANKS
·
29 May

Gain Therapeutics Price Target Maintained With a $8.00/Share by HC Wainwright & Co.

Dow Jones
·
19 May